Joseph Reilly

Clinical and Economic Benefits of Fidaxomicin Compared to Vancomycin for Clostridium difficile Infection

Jason C Gallagher, Joseph Reilly, Bhagyashri Navalkele et al. · Antimicrobial Agents and Chemotherapy · 2015 · 58 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Treatment considerations for coronavirus (COVID-19)

Joseph Reilly · Hospital Practice · 2020 · 13 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Expediting Discharge in Hospitalized, Adult Patients with Skin and Soft Tissue Infections Who Received Empiric Vancomycin Therapy with Oritavancin: Description of Findings from an Institutional Pathway

Cristen A Whittaker, Thomas P. Lodise, Ethan Nhan et al. · Drugs - Real World Outcomes · 2020 · 12 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Joseph Reilly, Micah A. Jacobs, Bruce Friedman et al. · Drugs - Real World Outcomes · 2020 · 11 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17